Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss.
about
Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706Is L-methionine a trigger factor for Alzheimer's-like neurodegeneration?: Changes in Aβ oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type miceHyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse modelThe amyloid beta ion channel hypothesis of Alzheimer's disease.Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases.Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.Back-scattering interferometry: an ultrasensitive method for the unperturbed detection of acetylcholinesterase-inhibitor interactions.Steamed and Fermented Ethanolic Extract from Codonopsis lanceolata Attenuates Amyloid-β-Induced Memory Impairment in Mice.Acetylcholine receptors in dementia and mild cognitive impairment.Inclusion body myositis: a view from the Caenorhabditis elegans muscle.Strategies for the inhibition of protein aggregation in human diseases.Huprines for Alzheimer's disease drug development.Octodon degus: a model for the cognitive impairment associated with Alzheimer's disease.Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders.Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and biological investigation.Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's diseaseAcetylcholinesterase inhibition and insulin resistance in late onset Alzheimer's disease.Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile.Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of Terminalia chebula: Cell-free In vitro and In silico Studies.Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease.Troxerutin protects hippocampal neurons against amyloid beta-induced oxidative stress and apoptosis.A new motif in the N-terminal of acetylcholinesterase triggers amyloid-β aggregation and deposition.In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile.Effects of beta-amyloid protein on M1 and M2 subtypes of muscarinic acetylcholine receptors in the medial septum-diagonal band complex of the rat: relationship with cholinergic, GABAergic, and calcium-binding protein perikarya.Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease.Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease.
P2860
Q21129335-DE6B99BC-36B3-42D2-8A17-609E5BD6B8EBQ27301311-C9EA1FF3-32E2-4D66-8AAD-58B02A3733EFQ34553059-B60A3E67-D693-4D63-B10E-3D6C23F7B559Q34797526-0292A57F-D966-416D-9DB9-27308613F121Q34965996-9F4C52A0-13D4-490C-9F6C-308FE2751851Q35165703-B0812884-5C33-4764-A1AA-77E3590158B4Q35247531-76DEE117-4E23-4C29-A0EF-57B8E899D807Q35757336-7257623D-B388-4F6F-A865-2A7FBF6685CBQ36269317-3AB8DABB-E0EA-4252-801B-61D5F0C5A9D0Q36622649-151E54B8-8A42-49E1-A80B-D3AE9E008B01Q36941964-D5859BB8-0485-41A9-9A0C-A44DBD7BBDEAQ36970193-D23AF093-8646-4F45-8E58-46A51006313FQ37070299-6AE869B5-BF7A-45D6-852C-D8CB783940F3Q37261432-E5DACBCC-D1F1-4980-9371-B3C000A88035Q37733418-0CEDBEF3-DBE6-4C6C-9FB1-BAB7081D478DQ38088283-FD0C4F25-3026-4CFC-B3A8-2CC661A59CA3Q38109655-FC187A77-A102-4AC8-839D-02A28DA3FDC7Q38262767-EDE19926-2EB4-4E2A-ADC7-D28CA6FC0AF0Q39097245-DF07653C-C990-4359-A2B4-C909FBAC7B3EQ39778610-441567B4-C9C8-42A5-9C39-F3F43FD2D19CQ39869084-47F91DC0-5DFA-4B45-99F8-2B7125D72C6EQ41813709-756B1526-6BEA-4B6A-9214-5AA25BCB0F0BQ45920578-72A57406-F753-41B5-AA6F-FCC0A8B78B77Q45924406-757F4DDF-DE44-4250-A953-750E4416F629Q46085377-B8A6313E-1793-48C6-B75E-00746885516CQ46119658-A785AD69-6ED8-4F03-8B0C-0BC0F00B31C9Q46260718-5F06A309-577A-49A9-9991-117FC26A3143Q46833725-E62C0F40-EB18-4B5B-9BCD-7108E1D9EB24Q47099682-10ECC711-7403-4F83-BAA1-7632345FD4F1Q47688215-35361A2E-F796-4763-A975-9A5CCDE57E06Q48258202-7021A7F0-2105-4391-98D3-DB2654BA8D38Q48275731-0B86F21A-A0D0-4E56-98F5-DED73F25ADAAQ48284096-60A64772-3E2B-4DAA-9809-3B82FEE9153AQ50435618-3BE1F845-FC7F-4DB7-832C-A6A2EE1AC30CQ50769472-A0AE8BD8-5334-4848-8191-5AA9A1D5B265Q53333065-F53AB34D-56BA-4DD8-AEE9-91815F11AD29Q53458869-58DF8519-1E43-4696-A352-28E9831B75D3
P2860
Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Acetylcholinesterase-Abeta com ...... tosis, and neuronal cell loss.
@en
type
label
Acetylcholinesterase-Abeta com ...... tosis, and neuronal cell loss.
@en
prefLabel
Acetylcholinesterase-Abeta com ...... tosis, and neuronal cell loss.
@en
P2093
P2860
P1476
Acetylcholinesterase-Abeta com ...... tosis, and neuronal cell loss.
@en
P2093
Ariel E Reyes
Carlos Morgan
Marcelo A Chacón
Margarita C Dinamarca
Nibaldo C Inestrosa
Waldo Cerpa
P2860
P304
P356
10.1016/S0002-9440(10)63774-1
P407
P577
2004-06-01T00:00:00Z